Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

185 trials

NCT06235216
Recruiting
Sacituzumab govitEcan in THYroid Cancers
Phase 2 · Spain · 11 sites
Registry update: 16 Sept 2026
NCT06800482
Recruiting
A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
Not applicable · China · 1 site
Registry update: 30 Jan 2025
2023-504898-20-00
Recruiting
A multicenter, open label, two cohort, single arm, phase II study to evaluate the efficacy and safety of the anti-TROP2 antibody-drug conjugate sacituzumab govitecan in patients with advanced differentiated and anaplastic thyroid neoplasms.
Phase 2 · Spain · 11 sites
Registry update: 17 Mar 2026
NCT06458036
Recruiting
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Phase 2 · United States · 5 sites
Registry update: 24 Jul 2026
NCT06787911
Recruiting
Donafenib Combined With Anti-PD-1 Antibody for Neoadjuvant Therapy in Locally Advanced Thyroid Cancer
Phase 2 · China · 1 site
Registry update: 22 Jan 2025
NCT06530316
Recruiting
RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer
Not applicable · China · 1 site
Registry update: 2 Aug 2024
NCT06440850
Recruiting
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
Phase 2 · United States · 1 site
Registry update: 2 Feb 2026
NCT06558981
Recruiting
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Phase 3 · China · 1 site
Registry update: 27 Feb 2026
NCT06524167
Recruiting
RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer
Not applicable · China · 1 site
Registry update: 27 Feb 2026
NCT06133374
Recruiting
Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples
Not applicable · Canada · 1 site
Registry update: 15 Jan 2026
NCT06431620
Recruiting
Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer
Not applicable · China · 1 site
Registry update: 28 May 2024
NCT06239194
Recruiting
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/2 · United States · 6 sites
Registry update: 15 Oct 2026
NCT07600580
Recruiting
The Association Between Bilateral Intermediate Cervical Plexus Block During Total Thyroidectomy and Surgical Stress Response
Phase 4 · Croatia · 1 site
Registry update: 16 Jun 2026
NCT07870148
Recruiting
Cross Immune Response Between Breast Carcinoma and Thyroid Autoimmunity: Impact on Prognosis and Treatment
Not applicable · Italy · 1 site
Registry update: 13 Oct 2026
NCT06738888
Recruiting
Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy
Not applicable · China · 1 site
Registry update: 8 Oct 2026
NCT06405217
Recruiting
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
Not applicable · China · 1 site
Registry update: 8 May 2024
NCT06316895
Recruiting
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
Not applicable · China · 1 site
Registry update: 20 Mar 2026
NCT06374602
Recruiting
Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Phase 2 · Russia · 1 site
Registry update: 5 Sept 2025
NCT06254859
Recruiting
Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery
Not applicable · China · 1 site
Registry update: 20 May 2025
NCT05783323
Recruiting
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Phase 2 · United States · 6 sites
Registry update: 21 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.